Experts say early results from Avandia study not reassuring, despite Glaxo's claim

(AP) - The maker of the controversial diabetes pill Avandia on Tuesday published preliminary results of a study that the company claims show the drug does not raise heart risks. However, experts say the results are inconclusive and even seem to suggest more risk from the drug....More